Rauner M - Search Results

1

Imatinib mesylate and nilotinib decrease synthesis of bone matrix in vitro.

Kroschwald LM, Tauer JT, Kroschwald SI, Suttorp M, Wiedenfeld A, Beissert S, Bauer A, Rauner M. Kroschwald LM, et al. Among authors: rauner m. Oncol Lett. 2019 Aug;18(2):2102-2108. doi: 10.3892/ol.2019.10518. Epub 2019 Jun 21. Oncol Lett. 2019. PMID: 31423283 Free PMC article.

2

The anti-progestin RU-486 inhibits viability of MCF-7 breast cancer cells by suppressing WNT1.

Benad P, Rauner M, Rachner TD, Hofbauer LC. Benad P, et al. Among authors: rauner m. Cancer Lett. 2011 Dec 15;312(1):101-8. doi: 10.1016/j.canlet.2011.08.006. Epub 2011 Aug 11. Cancer Lett. 2011. PMID: 21899945

3

Selective glucocorticoid receptor modulation maintains bone mineral density in mice.

Thiele S, Ziegler N, Tsourdi E, De Bosscher K, Tuckermann JP, Hofbauer LC, Rauner M. Thiele S, et al. Among authors: rauner m. J Bone Miner Res. 2012 Nov;27(11):2242-50. doi: 10.1002/jbmr.1688. J Bone Miner Res. 2012. PMID: 22714558 Free article.

4

Dickkopf-1 as a mediator and novel target in malignant bone disease.

Rachner TD, Göbel A, Benad-Mehner P, Hofbauer LC, Rauner M. Rachner TD, et al. Among authors: rauner m. Cancer Lett. 2014 May 1;346(2):172-7. doi: 10.1016/j.canlet.2014.01.010. Epub 2014 Jan 22. Cancer Lett. 2014. PMID: 24462802 Review.

5

Targeting syndecan-1 in breast cancer inhibits osteoclast functions through up-regulation of osteoprotegerin.

Benad-Mehner P, Thiele S, Rachner TD, Göbel A, Rauner M, Hofbauer LC. Benad-Mehner P, et al. Among authors: rauner m. J Bone Oncol. 2013 Nov 15;3(1):18-24. doi: 10.1016/j.jbo.2013.11.001. eCollection 2014 Mar. J Bone Oncol. 2013. PMID: 26909290 Free PMC article.

6

Plasma levels of Semaphorin 4D are decreased by adjuvant tamoxifen but not aromatase inhibitor therapy in breast cancer patients.

Göbel A, Kuhlmann JD, Link T, Wimberger P, Link-Rachner C, Thiele S, Dell'Endice S, Furesi G, Breining D, Rauner M, Hofbauer LC, Rachner TD. Göbel A, et al. Among authors: rauner m. J Bone Oncol. 2019 Apr 4;16:100237. doi: 10.1016/j.jbo.2019.100237. eCollection 2019 Jun. J Bone Oncol. 2019. PMID: 31011525 Free PMC article.

7

Thyroid Hormone Actions and Bone Remodeling - The Role of the Wnt Signaling Pathway.

Lademann F, Tsourdi E, Hofbauer LC, Rauner M. Lademann F, et al. Among authors: rauner m. Exp Clin Endocrinol Diabetes. 2020 Jun;128(6-07):450-454. doi: 10.1055/a-1088-1215. Epub 2020 Jan 20. Exp Clin Endocrinol Diabetes. 2020. PMID: 31958849 Review.

8

Thyroid hormone receptor Thra and Thrb knockout differentially affects osteoblast biology and thyroid hormone responsiveness in vitro.

Lademann F, Tsourdi E, Hofbauer LC, Rauner M. Lademann F, et al. Among authors: rauner m. J Cell Biochem. 2023 Dec;124(12):1948-1960. doi: 10.1002/jcb.30500. Epub 2023 Nov 22. J Cell Biochem. 2023. PMID: 37992217

9

Dissociation of osteogenic and immunological effects by the selective glucocorticoid receptor agonist, compound A, in human bone marrow stromal cells.

Rauner M, Goettsch C, Stein N, Thiele S, Bornhaeuser M, De Bosscher K, Haegeman G, Tuckermann J, Hofbauer LC. Rauner M, et al. Endocrinology. 2011 Jan;152(1):103-12. doi: 10.1210/en.2010-0456. Epub 2010 Nov 17. Endocrinology. 2011. PMID: 21084452

10

miR-125b regulates calcification of vascular smooth muscle cells.

Goettsch C, Rauner M, Pacyna N, Hempel U, Bornstein SR, Hofbauer LC. Goettsch C, et al. Among authors: rauner m. Am J Pathol. 2011 Oct;179(4):1594-600. doi: 10.1016/j.ajpath.2011.06.016. Epub 2011 Jul 30. Am J Pathol. 2011. PMID: 21806957 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

230 results

Search Page